Other languages DIAGNOS Inc.

Equities

ADK

CA2524423068

Delayed Toronto S.E. Other stock markets 09:39:02 2024-04-23 am EDT			5-day change	1st Jan Change
0.3 ^CAD	+1.69%		0.00%	-25.93%

Apr. 16	DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification	CI
Apr. 02	DIAGNOS Inc. Appoints Philippe Couillard to Its Board of Directors	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DIAGNOS Inc. to Expedite Application for Medical Device License to Health Canada and US FDA Related to its 4 New Analysis Modules, and is Planning ISO 27001 Certification	Apr. 16
DIAGNOS Inc. Appoints Philippe Couillard to Its Board of Directors	Apr. 02
Diagnos Announces Grant Of Stock Options	Mar. 04
DIAGNOS Inc. Appoints Michael Braeuel to Board of Directors	Feb. 29
DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 28
DIAGNOS Announces Closing Of First Tranche Of Private Placement	Feb. 27
Diagnos Inc. Appoints Yves-Stéphane Couture as Chief Operating Officer	Jan. 16
Diagnos Secures Exclusive Distribution Agreement for Canada with EssilorLuxottica	Dec. 11
Diagnos Inc. Secures Exclusive Distribution Agreement for Canada with Essilorluxottica	Dec. 11
DIAGNOS Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 28
DIAGNOS : 2023-10-05, L’analyse de la rétine par DIAGNOS IA est en cours de déploiement chez le plus grand fournisseur de soins spécialisés en diabète et en endocrinologie au Canada – En savoir plus	23-10-05
DIAGNOS Inc. Announces Commencement of its Innovative Deployment in an Advanced Screening Program At Canada's Presented Specialist Care Provider in Diabetes and Endocrinology	23-10-05
DIAGNOS Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-24
DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-13
DIAGNOS Inc. Auditor Raises 'Going Concern' Doubt	23-07-12
DIAGNOS : 2023-05-17, DIAGNOS et IRIS, Le Groupe Visuel renforcent leur partenariat avec le lancement de « IRIS-ai propulsé par DIAGNOS » – En savoir plus	23-05-17
Diagnos Announces Launch of "IRIS-ai powered by DIAGNOS"	23-05-17
DIAGNOS Inc. and IRIS, The Visual Group Strengthens Partnership with the Launch of "IRIS-ai Powered by DIAGNOS"	23-05-17
Diagnos and ETS Unveil Method to Adapt Deep Learning Algorithms	23-02-28
DIAGNOS and ETS to Present Research on Mass Screening for Macular Edema at ARVO 2023	23-02-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages DIAGNOS Inc.

Equities

ADK

CA2524423068

Other languages

Filters